Unlocking mRNA’s cancer-fighting potential
MIT spinout Strand Therapeutics has developed a new class of mRNA molecules that can sense where they are in the body, for more targeted and powerful treatments.
MIT spinout Strand Therapeutics has developed a new class of mRNA molecules that can sense where they are in the body, for more targeted and powerful treatments.
Joining three teams backed by a total of $75 million, MIT researchers will tackle some of cancer’s toughest challenges.
With the new technique, MIT researchers hope to identify mutations that could be targeted with new cancer therapies.
The technology could offer a cheap, fast way to test for PFAS, which have been linked to cancer and other health problems.
Stimulating gamma brain waves may protect cancer patients from memory impairment and other cognitive effects of chemotherapy.
A new study finds precancerous colon cells turn on a gene called SOX17, which helps them evade detection and develop into more advanced tumors.
MIT spinout Elicio developed a vaccine based on a lymph node-targeting approach first developed at the Koch Institute. Phase 1 solid tumor clinical trial results are promising so far.
A plastic microfluidic chip can remove some risky cells that could potentially become tumors before they are implanted in a patient.
A new microscopy technique that enables high-resolution imaging could one day help doctors diagnose and treat brain tumors.
The MIT professor emerita and pioneering molecular biologist is being honored for her advocacy for women in science.
A compound originally developed to treat cancer could be repurposed to treat polycystic kidney disease, an inherited condition that can lead to kidney failure.
The advance makes it easier to detect circulating tumor DNA in blood samples, which could enable earlier cancer diagnosis and help guide treatment.
MIT CSAIL researchers develop advanced machine-learning models that outperform current methods in detecting pancreatic ductal adenocarcinoma.
The diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible worldwide.
By reevaluating existing data, researchers find the procedure is even more valuable than consensus had indicated.